IP Library Granted Patent US 9,585,875
Granted Patent B2
US 9,585,875 · App. 14/366,796 · Granted Mar 7, 2017

TRPM8 antagonists

Inventors: Alessio Moriconi (L'Aquila, IT); Gianluca Bianchini (L'Aquila, IT); Sandro Colagioia (L'Aquila, IT); Laura Brandolini (L'Aquiula, IT); Andrea Aramini (L'Aquila, IT); Chiara Liberati (Via Olgettina, IT); Silvia Bovolenta (Via Olgettina, IT)
Assignee: DOMPÉ FARMACEUTICI S.P.A.
A61K31/426A61K31/421A61K31/4245A61K31/4439A61K31/472C07D263/42C07D277/56C07D417/04C07D417/10C07D417/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,875
App. No.
14/366,796
Granted
Mar 7, 2017
Kind
B2
Abstract

The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exhacerbated respiratory disorders and urological disorders.

Claims (160)

1. A method for the treatment of a disease associated with the activity of TRPM8, wherein the disease is selected from itch, irritable bowel diseases, cold-induced and/or exacerbated respiratory disorders, ischaemia, urological disorders, stroke, psychiatric disorders, neuropathic pain, postoperative pain, cancer pain, rheumatoid arthritic pain, neuralgia, fibromyalgia, neuropathies, fibromyalgia, algesia, nerve injury, migraine, headache, painful bladder syndrome, interstitial cystitis, detrusor overactivity, urinary incontinence, neurogenic detrusor overactivity, idiopathic detrusor overactivity, benign prostatic hyperplasia, lower urinary tract disorders and lower urinary tract symptoms, anxiety, depression and cold-induced/or exacerbated pulmonary hypertension, COPD, and asthma, the method comprising administering to a patient in need thereof a compound having formula I:

or a pharmaceutically acceptable salt thereof,

wherein:

X is selected from S or O;

R 1 is selected from the group consisting of:

—OR 5 wherein R 5 is selected from H; C 1 -C 4 alkyl, trifluoromethanesulfonyl, benzyl, (trifluoromethyl)benzyl, (halo)benzyl, (trifluoromethyl)benzoyl, N-benzylcarbamoyl, cyclohexyloxyacetoyl substituted with at least one C 1 -C 3 alkyl group, (C 1 -C 3 alkoxy)methyl, C 1 -C 3 alkanoyl and CH 2 CH 2 NHR 6 , wherein

R 6 is selected from H and (furan-2-yl)methyl;

—NHR 7 wherein R 7 is selected from H, tert-butoxycarbonyl, C 1 -C 3 alkanoyl, (4-trifluoromethyl)benzoyl, N-phenylaminoacarbonyl, CH 2 R 8 , wherein

R 8 is selected from phenyl, benzo[d][1,3] dioxole, pyridin-3-yl, (pyrrolidin-1-yl)methyl, —CH 2 NHR 9 wherein

R 9 is selected from H, C 1 -C 3 alkyl and cycloalkyl;

R 2 is selected from the group consisting of

—COOR 10 wherein

R 10 is selected from H, C 1 -C 3 alkyl and cyclohexyl, optionally substituted with at least one C 1 -C 3 alkyl group;

—OH; —CONH 2 ; CN

-tetrazol-5-yl or 1-(C 1 -C 3 alkyl)tetrazol-5-yl,

-5-(C 1 -C 3 alkyl)1,2,4 triazol-3-yl,

-5-(C 1 -C 3 alkyl) 1,2,4-oxadiazol-3yl,

-5-(C 1 -C 3 alkyl) 1,3,4-oxadiazol-2-yl;

R 3 is selected from F or H,

R 4 is selected from H, CH 3 , halogen, dimethylamino, pyridin-4-yl, phenyl, 2- or 4-(halo)phenyl, 2- or 4-(trifluoromethyl)phenyl and 2- and/or 4-halobenzyloxy.

2. The method of claim 1 , wherein

when R 3 is F, R 3 is in position ortho of the aromatic ring and R 4 is F in position para of the aromatic ring.

3. The method of claim 1 , wherein

when R 3 is H, R 4 is in position para or meta on the aromatic ring.

4. The method of claim 1 , wherein

R 5 is selected from H; C 1 -C 4 alkyl; trifluoromethanesulfonyl; benzyl; (trifluoromethyl)benzyl, (chloro)benzyl; (trifluoromethyl)benzoyl, N-benzylcarbamoyl, cyclohexyloxyacetoyl substituted with at least one C 1 -C 3 alkyl group, (methoxy)methyl, propanoyl and —CH 2 CH 2 NHR 6 ;

wherein R 6 is selected from H and (furan-2-yl)methyl.

5. The method of claim 1 , wherein

R 7 is selected from H, tert-butoxycarbonyl, acetyl, (4-trifluoromethyl)benzoyl; N-phenylaminoacarbonyl, CH 2 R 8 , wherein

R 8 is selected from phenyl, benzo[d][1,3] dioxole, pyridin-3-yl, (pyrrolidin-1-yl)methyl, —CH 2 NHR 9 wherein

R 9 is selected from H, C 1 -C 3 alkyl and cyclopentyl.

6. The method of claim 1 , wherein

R 10 is selected from H; C 1 -C 3 alkyl and 2-isopropyl-5-methyl-cyclohexyl.

7. The method of claim 1 , wherein:

R 4 is selected from H; CH 3 , F; Cl; dimethylamino; pyridin-4-yl; phenyl, 2-F-phenyl, 2-trifluoromethylphenyl; 2- or 4-halobenzyloxy.

8. The method of claim 1 , wherein R 1 is selected from:

OR 5 , wherein R 5 is selected from H, benzyl, (chloro)benzyl, (trifluoromethyl)benzoyl; and

CH 2 —CH 2 NH 2 ; and

NHCH 2 CH 2 R 9 wherein R 9 is selected from C 1 -C 3 alkyl and H.

9. The method of claim 1 , wherein R 2 is COOR 10 wherein R 10 is selected from H, C 1 -C 3 alkyl.

10. The method of claim 1 , wherein R 3 is H.

11. The method of claim 1 , wherein said compound of formula I is selected from:

2-(4-chlorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylic acid (1)

4-hydroxy-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (2)

2-(3-fluorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylic acid (3)

2-(4-fluorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylic acid (4)

methyl 4-hydroxy-2-phenyl-1,3-thiazole-5-carboxylate (5)

methyl 2-(2,4-difluorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate (6)

ethyl 4-hydroxy-2-phenyl-1,3-thiazole-5-carboxylate (7)

ethyl 2-(4-chlorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate (8)

ethyl 4-hydroxy-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (9)

ethyl 2-(3-fluorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate (10)

ethyl 2-(4-fluorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate (11)

ethyl 4-hydroxy-2-(pyridin-4-yl)-1,3-thiazole-5-carboxylate (12)

ethyl 2-[4-(dimethylamino)phenyl]-4-hydroxy-1,3-thiazole-5-carboxylate (13)

ethyl 2-(3-chlorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate (14)

ethyl 4-hydroxy-2-[2′-(trifluoromethyl)biphenyl-3-yl]-1,3-thiazole-5-carboxylate (15)

ethyl 2-(2′-fluorobiphenyl-3-yl)-4-hydroxy-1,3-thiazole-5-carboxylate (16)

ethyl 4-hydroxy-2-[2′-(trifluoromethyl)biphenyl-4-yl]-1,3-thiazole-5-carboxylate (17)

ethyl 2-(2′-fluorobiphenyl-4-yl)-4-hydroxy-1,3-thiazole-5-carboxylate (18)

ethyl 2-{4-[(2-fluorobenzyl)oxy]phenyl}-4-hydroxy-1,3-thiazole-5-carboxylate (19)

ethyl 2-{4-[(4-fluorobenzyl)oxy]phenyl}-4-hydroxy-1,3-thiazole-5-carboxylate (20)

ethyl 2-(4-fluorophenyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-1,3-thiazole-5-carboxylate (21)

ethyl 4-methoxy-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (22)

ethyl 2-(4-methylphenyl)-4-(2-methylpropoxy)-1,3-thiazole-5-carboxylate (23)

ethyl 4-(benzyloxy)-2-phenyl-1,3-thiazole-5-carboxylate (24)

ethyl 4-[(3-chlorobenzyl)oxy]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (25)

ethyl 4-[(3-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (26)

ethyl 4-[(4-chlorobenzyl)oxy]-2-phenyl-1,3-thiazole-5-carboxylate (27)

ethyl 4-[(4-chlorobenzyl)oxy]-2-(3-chlorophenyl)-1,3-thiazole-5-carboxylate (28)

ethyl 4-[(4-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (29)

ethyl 4-[(4-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (30)

ethyl 4-[(2-chlorobenzyl)oxy]-2-phenyl-1,3-thiazole-5-carboxylate (31)

ethyl 4-[(2-chlorobenzyl)oxy]-2-(4-fluorophenyl)-1,3-thiazole-5-carboxylate (32)

ethyl 4-[(2-chlorobenzyl)oxy]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (33)

ethyl 4-[(2-chlorobenzyl)oxy]-2-(3-chlorophenyl)-1,3-thiazole-5-carboxylate (34)

ethyl 4-[(2-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (35)

ethyl 2-phenyl-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylate (36)

ethyl 2-(3-fluorophenyl)-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylate (37)

ethyl 2-(4-methylphenyl)-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylate (38)

ethyl4-(2-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)acetoyloxy)-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (39)

ethyl 4-[(benzylcarbamoyl)oxy]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (40)

ethyl 4-(2-aminoethoxy)-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (41)

ethyl 2-(4-chlorophenyl)-4-{2-[(furan-2-ylmethyl)amino]ethoxy}-1,3-thiazole-5-carboxylate (42)

4-[(4-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (43)

4-[(4-chlorobenzyl)oxy]-2-phenyl-1,3-thiazole-5-carboxylic acid (44)

4-[(4-chlorobenzyl)oxy]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylic acid (45)

4-[(4-chlorobenzyl)oxy]-2-(3-chlorophenyl)-1,3-thiazole-5-carboxylic acid (46)

4-(benzyloxy)-2-phenyl-1,3-thiazole-5-carboxylic acid (47)

4-[(3-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylic acid (48)

4-[(2-chlorobenzyl)oxy]-2-phenyl-1,3-thiazole-5-carboxylic acid (49)

4-[(2-chlorobenzyl)oxy]-2-(4-fluorophenyl)-1,3-thiazole-5-carboxylic acid (50)

4-[(2-chlorobenzyl)oxy]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylic acid (51)

4-[(2-chlorobenzyl)oxy]-2-(3-chlorophenyl)-1,3-thiazole-5-carboxylic acid (52)

4-[(2-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (53)

4-[(2-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylic acid (54)

2-phenyl-4-{[4-(trifluoromethyl)benzyl]oxy}-1,3-thiazole-5-carboxylic acid (55)

2-(3-fluorophenyl)-4-{[4-(trifluoromethyl)benzyl]oxy}-1,3-thiazole-5-carboxylic acid (56)

2-phenyl-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylic acid (57)

2-(3-fluorophenyl)-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylic acid (58)

2-(4-methylphenyl)-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-thiazole-5-carboxylic acid (59)

4-methoxy-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (60)

2-(4-methylphenyl)-4-(2-methylpropoxy)-1,3-thiazole-5-carboxylic acid (61)

ethyl 4-[(tert-butoxycarbonyl)amino]-2-(4-fluorophenyl)-1,3-thiazole-5-carboxylate (62)

ethyl 4-amino-2-(4-fluorophenyl)-1,3-thiazole-5-carboxylate hydrochloride (63)

ethyl 4-(acetylamino)-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (64)

ethyl 2-(4-methylphenyl)-4-{[4-(trifluoromethyl)benzoyl]amino}-1,3-thiazole-5-carboxylate (65)

ethyl 2-(4-methylphenyl)-4-[(phenylcarbamoyl)amino]-1,3-thiazole-5-carboxylate (66)

ethyl 4-[(2-aminoethyl)amino]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (67)

ethyl 2-(4-chlorophenyl)-4-{[2-(methylamino)ethyl]amino}-1,3-thiazole-5-carboxylate (68)

ethyl 2-(4-chlorophenyl)-4-{[2-(propylamino)ethyl]amino}-1,3-thiazole-5-carboxylate (69)

ethyl 4-[(2-aminoethyl)amino]-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (70)

ethyl 4-{[2-(methylamino)ethyl]amino}-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (71)

ethyl 4-[(2-aminoethyl)amino]-2-[2′-(trifluoromethyl)biphenyl-4-yl]-1,3-thiazole-5-carboxylate (72)

ethyl 4-[(2-aminoethyl)amino]-2-[2′-(trifluoromethyl)biphenyl-3-yl]-1,3-thiazole-5-carboxylate (73)

ethyl 2-(4-chlorophenyl)-4-{[2-(cyclopentylamino)ethyl]amino}-1,3-thiazole-5-carboxylate (74)

ethyl 2-phenyl-4-{[2-(pyrrolidin-1-yl)ethyl]amino}-1,3-thiazole-5-carboxylate (75)

ethyl 4-(benzylamino)-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (76)

ethyl 4-[(1,3-benzodioxol-5-ylmethyl)amino]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (77)

ethyl 2-(3-fluorophenyl)-4-[(pyridin-3-ylmethyl)amino]-1,3-thiazole-5-carboxylate (78)

4-[(2-aminoethyl)amino]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (79)

4-{[2-(methylamino)ethyl]amino}-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid (80)

4-[(2-aminoethyl)amino]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylic acid (81)

sodium 4-[(3-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (82)

sodium 4-[(4-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (83)

sodium 4-(4-chlorobenzyloxy)-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (84)

sodium 4-(2-chlorobenzyloxy)-2-(4-chlorophenyl)-1,3-thiazole-5-carboxylate (85)

sodium 4-(2-chlorobenzyloxy)-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (86)

sodium 4-(2-chlorobenzyloxy)-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (87)

sodium 4-(4-chlorobenzyloxy)-2-(3-fluorophenyl)-1,3-thiazole-5-carboxylate (88)

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl-4-(benzyloxy)-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (89)

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl-4-hydroxy-2-(4-methylphenyl)-1,3-thiazole-5-carboxylate (90)

ethyl 2-(4-chlorophenyl)-4-(methoxymethoxy)-1,3-thiazole-5-carboxylate (91)

2-(4-chlorophenyl)-4-(methoxymethoxy)-1,3-thiazole-5-carboxylic acid (92)

2-(4-chlorophenyl)-4-(methoxymethoxy)-1,3-thiazole-5-carboxamide (93)

2-(4-chlorophenyl)-4-(methoxymethoxy)-1,3-thiazole-5-carbonitrile (94)

2-(4-chlorophenyl)-5-(1H-tetrazol-5-yl)-1,3-thiazol-4-ol (95)

2-(4-chlorophenyl)-5-(1-methyl-1H-tetrazol-5-yl)-1,3-thiazol-4-ol (96)

2-(3-fluorophenyl)-5-(1-methyl-1H-tetrazol-5-yl)-1,3-thiazol-4-ol (97)

2-(4-chlorophenyl)-5-(5-methyl-4H-1,2,4-triazol-3-yl)-1,3-thiazol-4-ol (98)

2-(3-fluorophenyl)-5-(5-methyl-4H-1,2,4-triazol-3-yl)-1,3-thiazol-4-ol (99)

2-(4-chlorophenyl)-5-(5-methyl-1,2,4-oxadiazol-3-yl)-1,3-thiazol-4-ol (100)

2-(3-fluorophenyl)-5-(5-methyl-1,2,4-oxadiazol-3-yl)-1,3-thiazol-4-ol (101)

3-{4-[(4-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-thiazol-5-yl}-5-methyl-1,2,4-oxadiazole (102)

2-(4-chlorophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-4-ol (103)

2-(3-fluorophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-4-ol (104)

ethyl 4-hydroxy-2-phenyl-1,3-oxazole-5-carboxylate (105)

ethyl 2-(3-fluorophenyl)-4-hydroxy-1,3-oxazole-5-carboxylate (106)

ethyl 4-hydroxy-2-(4-methylphenyl)-1,3-oxazole-5-carboxylate (107)

ethyl 4-[(4-chlorobenzyl)oxy]-2-phenyl-1,3-oxazole-5-carboxylate (108)

ethyl 4-[(4-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-oxazole-5-carboxylate (109)

ethyl 4-[(4-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-oxazole-5-carboxylate (110)

ethyl 2-phenyl-4-{[4-(trifluoromethyl)benzoyl]oxy}-1,3-oxazole-5-carboxylate (111)

4-[(4-chlorobenzyl)oxy]-2-phenyl-1,3-oxazole-5-carboxylic acid (112)

4-[(4-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-oxazole-5-carboxylic acid (113)

4-[(4-chlorobenzyl)oxy]-2-(4-methylphenyl)-1,3-oxazole-5-carboxylic acid (114)

2-(3-fluorophenyl)-5-(5-methyl-1,2,4-oxadiazol-3-yl)-1,3-oxazol-4-ol (115)

3-{4-[(4-chlorobenzyl)oxy]-2-(3-fluorophenyl)-1,3-oxazol-5-yl}-5-methyl-1,2,4-oxadiazole (116)

ethyl 2-(3-fluorophenyl)-5-hydroxy-1,3-thiazole-4-carboxylate (117)

2-(3-fluorophenyl)-5-(2-ethyl-2H-tetrazol-5-yl)-1,3-thiazol-4-ol (118).

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S ADDRESS PREVIOUSLY RECORDED AT REEL: 036914 FRAME: 0863. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Oct 6, 2016
From: DOMPÉ S.P.A.
To: DOMPÉ FARMACEUTICI S.P.A.
Reel/Frame 040246/0700 →
MERGER Recorded Oct 29, 2015
From: DOMPÉ S.P.A.
To: DOMPÉ FARMACEUTICI S.P.A.
Reel/Frame 036914/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: MORICONI, ALESSIO; BIANCHINI, GIANLUCA; COLAGIOIA, SANDRO; BRANDOLINI, LAURA; ARAMINI, ANDREA; LIBERATI, CHIARA; BOVOLENTA, SILVIA
To: DOMPE' S.P.A.
Reel/Frame 034549/0046 →
Priority Claims (2)
EP 11194365 · Dec 19, 2011 · regional
EP 12178327 · Jul 27, 2012 · regional
Continuity (1)
Related Publication 20140371276A1 · Dec 18, 2014